Update on Management of Dural Arteriovenous Fistulas
-
Published:2022-09-29
Issue:
Volume:3
Page:11-26
-
ISSN:2766-9696
-
Container-title:Journal of Rare Diseases and Orphan Drugs
-
language:
-
Short-container-title:jrdod
Author:
Azab Mohammed A,Dioso Emma R,Findlay Matthew C,Nelson Jayson,Rawanduzy Cameron A,Johansen Philip,Lucke-Wold Brandon
Abstract
Abstract: Dural Arteriovenous Fistulas (AVF) represent about 10% of all intracranial vascular lesions. Although they seem benign in nature, the presence of retrograde venous makes them aggressive, with a high risk of complications. Patients may be clinically asymptomatic or experience symptoms ranging from mild to severe hemorrhage, depending on their location. Different treatments are available, but recently, the development of catheter intervention allows most patients to be cured with transcatheter embolization. Stereotactic radiosurgery achieves excellent rates of obliteration for low-grade lesions. In this review, we try to highlight the recent advances in the management of dural AVF.
Publisher
SciencePower Publishing House LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献